30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Kassberg Thomas Richard

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 13% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Kassberg Thomas Richard's trades of Ultragenyx Pharmaceutical Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-04 2025-03-03
S Sale
39,204 +49.8%
89.23
US$2,713,798 		39,204 +49.8% 89.23 US$2,713,798
2024-03-12 2024-03-11
S Sale
89,002 -23.6%
365.66
US$3,992,361 		89,002 -23.6% 365.66 US$3,992,361
2024-03-11 2024-03-11
PrS Proposed sale
3,213
301.69
US$2,909,344 		3,213 301.69 US$2,909,344
2024-03-05 2024-03-01
S Sale
1,011 -0.4%
53.76
US$54,351 		1,011 -0.4% 53.76 US$54,351
2023-10-24 2023-10-23
S Sale
39,878 -13.9%
32.78
US$1,307,201 		39,878 -13.9% 32.78 US$1,307,201
2023-10-23 2023-10-23
PrS Proposed sale
39,878
32.78
US$1,307,077 		39,878 32.78 US$1,307,077
2023-03-03 2023-03-01
S Sale
1,968 -0.8%
45.27
US$89,091 		1,968 -0.8% 45.27 US$89,091
2022-03-15 2022-03-11
S Sale
10,281 -4.3%
67.01
US$688,930 		10,281 -4.3% 67.01 US$688,930
2022-03-03 2022-03-01
S Sale
2,374 -1.1%
66.62
US$158,156 		2,374 -1.1% 66.62 US$158,156
2021-10-18 2021-10-14
S Sale
286 -0.1%
81.14
US$23,206 		286 -0.1% 81.14 US$23,206
2021-03-03 2021-03-01
PlS Planned sale
4,572 -4.1%
138.17
US$631,713 		4,572 -4.1% 138.17 US$631,713
2020-10-16 2020-10-14
S Sale
262 -0.3%
87.98
US$23,051 		262 -0.3% 87.98 US$23,051